News items related to: News
-
Possible treatments for COVID-19 could all be made for $1 a day, say researchers: Pharma must not profit from a pandemic and countries must ACT NOW.
Drugs currently being used in COVID-19 treatment trials can all be mass-produced affordably, research from the University of Liverpool, published...
-
Open letter: COVID-19 underlines the need for 37 World Trade Organization members to reverse a critical decision
As the International Treatment Preparedness Coalition (ITPC), we have signed an open letter asking 37 World Trade Organization members to...
-
Letter urges Gilead to ensure everyone can access its “promising” COVID-19 treatment pending clinical trial results
ITPC has joined the more than 150 civil society organizations and individuals expressing concerns in a letter to Gilead, coordinated...
-
Activists urge Indonesia’s govt to resolve HIV drugs shortage amid COVID-19 pandemic
We reported how stockouts, since January this year, have been leaving people living with HIV without their essential treatment in...
-
“People with TB were being routinely imprisoned.” Overhauling Kenya’s TB response, and what the country’s impending COVID-19 crisis can adopt from it.
Our campaign partner, KELIN, has helped transform how people living with TB are treated. Their work set a precedent, ending...
-
Civil society demands an end to ARV stockouts in Indonesia
Our partner, the Indonesian AIDS Coalition (IAC) is one of 73 organizations, calling on the country’s Ministry of Health to...
-
Opportunities for Access: The second Global Summit on Intellectual Property and Access to Medicines
The second Global Summit on Intellectual Property (IP) and Access to Medicines (GSIPA2M) will take place in Marrakesh, Morocco, 2-4...
-
Indonesia: Community action results in cheaper HIV treatment
First published by The Jakarta Post. Indonesia has an increasing rate of new HIV infections, with approximately 46,000 people newly...
-
Activists ask pharma corporations: “Is the Middle East and North Africa a priority?”
A CAB meeting was held in Morocco, providing an opportunity to discuss access to treatment in a region facing an...
-
We can’t end AIDS without tackling patent abuse
Despite significant scientific advancements for HIV, along with global and national commitments to ‘end AIDS’, hundreds of thousands of people...
-
TEDWomen: Why are drug prices so high?
Hear from I-MAK’s Priti Krishtel on how the outdated patent system is the hidden reason that drug prices are so high...
-
ITPC’s Global Survey on Access to and Quality of HIV Treatment and Care
ITPC’s Global Survey on Access to and Quality of HIV Treatment and Care focused on barriers to quality HIV care...